Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FMR LLC | 16.95M | $420.0M | 8.31% | -42.9K | 2026-03-31 |
| Deep Track Capital, LP | 11.53M | $286.0M | 5.65% | -- | 2026-03-31 |
| BlackRock, Inc. | 6.57M | $163.0M | 3.22% | +516.3K | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 5.46M | $135.0M | 2.68% | -1.03M | 2026-03-31 |
| BAKER BROS. ADVISORS LP | 5.46M | $135.0M | 2.68% | -- | 2026-03-31 |
| STATE STREET CORP | 4.54M | $112.0M | 2.23% | +751.0K | 2026-03-31 |
| TCG Crossover Management, LLC | 4.46M | $110.0M | 2.19% | +2.80M | 2026-03-31 |
| MORGAN STANLEY | 3.88M | $96.0M | 1.90% | -969.5K | 2026-03-31 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.70M | $92.0M | 1.82% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.62M | $89.0M | 1.78% | -- | 2026-03-31 |
